Angiotensin-(1-7) : Pharmacology and new perspectives in cardiovascular treatmentsTRASK, Aaron J; FERRARIO, Carlos M.Cardiovascular drug reviews (Print). 2007, Vol 25, Num 2, pp 162-174, issn 0897-5957, 13 p.Article

Conivaptan : A dual receptor vasopressin V_1a/V₂ antagonistALI, Farhan; RAUFI, M. Adnan; WASHINGTON, Barbara et al.Cardiovascular drug reviews (Print). 2007, Vol 25, Num 3, pp 261-279, issn 0897-5957, 19 p.Article

A Review of Clinical Trials with Eptifibatide in CardiologyZEYMER, Uwe; WIENBERGEN, Harm.Cardiovascular drug reviews (Print). 2007, Vol 25, Num 4, pp 301-315, issn 0897-5957, 15 p.Article

C-reactive protein (CRP)-lowering agentsPRASAD, Kailash.Cardiovascular drug reviews (Print). 2006, Vol 24, Num 1, pp 33-50, issn 0897-5957, 18 p.Article

Prostanoids in the Therapy of GlaucomaISHIDA, Naruhiro; ODANI-KAWABATA, Noriko; SHIMAZAKI, Atsushi et al.Cardiovascular drug reviews (Print). 2006, Vol 24, Num 1, pp 1-10, issn 0897-5957, 10 p.Article

Role of adenosine as adjunctive therapy in acute myocardial infarctionFORMAN, Mervyn B; STONE, Gregg W; JACKSON, Edwin K et al.Cardiovascular drug reviews (Print). 2006, Vol 24, Num 2, pp 116-147, issn 0897-5957, 32 p.Article

Development of the thyroid hormone receptor β-subtype agonist KB-141 : A strategy for body weight reduction and lipid lowering with minimal cardiac side effectsGROVER, Gary J; MELLSTROM, Karin; MALM, Johan et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 2, pp 133-148, issn 0897-5957, 16 p.Article

Efficacy and safety of sitosterol in the management of blood cholesterol levelsLUZ FERNANDEZ, Maria; VEGA-LOPEZ, Sonia.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 1, pp 53-70, issn 0897-5957, 18 p.Article

Role of mitogen-activated protein (MAP) kinases in cardiovascular diseasesPANDYA, Nilesh; SANTANI, Dev; JAIN, Sunita et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 3, pp 247-254, issn 0897-5957, 8 p.Article

Clinical potential of lomerizine, a Ca²⁺ channel blocker as an anti-glaucoma drug: Effects on ocular circulation and retinal neuronal damageHARA, Hideaki; TORIU, Nobuko; SHIMAZAWA, Masamitsu et al.Cardiovascular drug reviews (Print). 2004, Vol 22, Num 3, pp 199-214, issn 0897-5957, 16 p.Article

Calcium antagonists in patients with type 2 diabetes and hypertensionMCFARLANE, Samy I; FARAG, Amal; SOWERS, James et al.Cardiovascular drug reviews (Print). 2003, Vol 21, Num 2, pp 105-118, issn 0897-5957, 14 p.Article

DX-9065a, a direct inhibitor of factor XaKAISER, Brigitte.Cardiovascular drug reviews (Print). 2003, Vol 21, Num 2, pp 91-104, issn 0897-5957, 14 p.Article

The P2Y₁ receptor as a target for new antithrombotic drugs: A review of the P2Y₁ antagonist MRS-2179BAURAND, Anthony; GACHET, Christian.Cardiovascular drug reviews (Print). 2003, Vol 21, Num 1, pp 67-76, issn 0897-5957, 10 p.Article

CVT-510: A selective A₁ adenosine receptor agonistCHEUNG, Jim W; LERMAN, Bruce B.Cardiovascular drug reviews (Print). 2003, Vol 21, Num 4, pp 277-292, issn 0897-5957, 16 p.Article

Stem cell therapy in ischemic heart diseaseSUNKOMAT, Julia N. E; GABALLA, Mohamed A.Cardiovascular drug reviews (Print). 2003, Vol 21, Num 4, pp 327-342, issn 0897-5957, 16 p.Article

BQ-788, a selective endothelin ET_B receptor antagonistOKADA, Megumu; NISHIKIBE, Masaru.Cardiovascular drug reviews (Print). 2002, Vol 20, Num 1, pp 53-66, issn 0897-5957Article

Rosuvastatin: A highly effective new HMG-CoA reductase inhibitorOLSSON, Anders G; MCTAGGART, Fergus; RAZA, Ali et al.Cardiovascular drug reviews (Print). 2002, Vol 20, Num 4, pp 303-328, issn 0897-5957, 26 p.Article

Angiotensin receptor blockers and the kidney : Possible advantages over ACE inhibition?COOPER, Mark E; WEBB, Randy L; DE GASPARO, Marc et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 1, pp 75-86, issn 0897-5957Article

Basic experimental studies and clinical aspects of gadolinium salts and chelatesADDING, L. Christofer; BANNENBERG, Gerard L; GUSTAFSSON, Lars E et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 1, pp 41-56, issn 0897-5957Article

UR-3216 : A manageable oral GPIIb/IIIa antagonistBABA, Kosuke; AGA, Yasuhiro; NAKANISHI, Takayuki et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 1, pp 25-40, issn 0897-5957Article

Xemilofiban/orbofiban : Insight into drug developmentANDERS, Robert; KLEIMAN, Jay; NICHOLSON, Nancy et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 2, pp 116-132, issn 0897-5957Article

A review of HNS-32: A novel azulene-1-carboxamidine derivative with multiple cardiovascular protective actionsTANAKA, Yoshio; SHIGENOBU, Koki.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 4, pp 297-312, issn 0897-5957Article

Cardiovascular properties of Yangambin, a lignan isolated from Brazilian plantsTIBIRICA, Eduardo.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 4, pp 313-328, issn 0897-5957Article

Ibudilast: A non-selective PDE inhibitor with multiple actions on blood cells and the vascular wallKISHI, Yukio; OTHA, Seiko; KASUYA, Natsuko et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 3, pp 215-225, issn 0897-5957Article

CGS 30440: A dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11COHEN, D. S; FINK, C. A; TRAPANI, A. J et al.Cardiovascular drug reviews (Print). 1999, Vol 17, Num 1, pp 16-38, issn 0897-5957Article